LL-37 is a naturally occurring antimicrobial peptide composed of 37 amino acids and represents the active form of the human cathelicidin antimicrobial peptide (hCAP18). Synthetic LL-37 has become widely studied in laboratory research involving innate immune signaling, microbial interactions, inflammatory pathways, cellular migration, and epithelial biology.

LL-37 research has explored its interactions with microbial membranes and its role within innate immune defense mechanisms. Researchers have investigated the structural properties that allow LL-37 to interact with lipid membranes, providing a model for studying peptide-membrane interactions and antimicrobial biology.

Another significant area of LL-37 research involves inflammatory and cellular signaling. Laboratory studies have examined its relationship with immune-cell communication, cytokine activity, epithelial response, cellular migration, and mechanisms associated with tissue remodeling and barrier biology.

LL-37 has a molecular weight of approximately 4,493 g/mol and can be synthetically produced for controlled research applications. It is typically supplied as a lyophilized powder for laboratory investigation involving innate immune biology, peptide-membrane interactions, inflammatory signaling, and related cellular processes.